Medical devices, healthcare technology and the business of care
PMA approval · P220002

TOPS System

Premia Spine, Ltd. · Decision date Jun 15, 2023

FDA DECISIONP220002

What did the FDA approve?

FDA records P220002 as an original PMA application. The recorded decision is approval, dated Jun 15, 2023.

FDA approval order statement

Approval for The TOPS System is a motion-preserving spinal implant that is inserted into the lumbar spine via pedicle screws. The TOPS System is intended to stabilize the spine following a lumbar decompression without rigid fixation.The TOPS System is indicated for patients between 35 and 80 years of age with symptomatic degenerative spondylolisthesis up to Grade I, with moderate to severe lumbar spinal stenosis and either the thickening of the ligamentum flavum and/or of the scarring facet joint capsule at one level from L3 to L5.
Regulatory pathway
Original PMA
Clinical specialty
Orthopedic
Decision date
Jun 15, 2023

FDA source record

Regulatory record facts

Identifier
P220002
Regulatory pathway
Premarket approval application
Product code
QWK
Decision code
APPR
Decision date
Jun 15, 2023
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, posterior spinal elements.

Product code
QWK
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P220002 received

    Application receipt date recorded by FDA.

  2. P220002 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P220002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220002

Product / regulatory recordCompanyPathwayDecision dateSource
TOPS SystemP220002/S011
Premia Spine, Ltd.PMA supplementSep 9, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Premia Spine, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
7 Giborey Israel St., Ramat Poleg, Netanya, 4250407

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records